• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利引入有组织的筛查后宫颈癌发病率的变化。

Changes in cervical cancer incidence following the introduction of organized screening in Italy.

作者信息

Serraino Diego, Gini Andrea, Taborelli Martina, Ronco Guglielmo, Giorgi-Rossi Paolo, Zappa Marco, Crocetti Emanuele, Franzo Antonella, Falcini Fabio, Visioli Carmen Beatriz, Stracci Fabrizio, Zorzi Manuel, Federico Massimo, Michiara Maria, Fusco Mario, Ferretti Stefano, Pannozzo Fabio, Tisano Francesco, Zanetti Roberto, Zucchetto Antonella

机构信息

Epidemiology and Biostatistics, CRO Aviano National Cancer Institute, Aviano, Italy.

Center for Cancer Epidemiology and Prevention, City of Health and Science Hospital, Torino, Italy.

出版信息

Prev Med. 2015 Jun;75:56-63. doi: 10.1016/j.ypmed.2015.01.034. Epub 2015 Mar 27.

DOI:10.1016/j.ypmed.2015.01.034
PMID:25818232
Abstract

OBJECTIVE

To quantify the impact of organized cervical screening programs (OCSPs) on the incidence of invasive cervical cancer (ICC), comparing rates before and after activation of OCSPs.

METHODS

This population-based investigation, using individual data from cancer registries and OCSPs, included 3557 women diagnosed with ICC at age 25-74years in 1995-2008. The year of full-activation of each OCSP was defined as the year when at least 40% of target women had been invited. Incidence rate ratios (IRRs) with 95% confidence intervals (95% CIs) were calculated as the ratios between age-standardized incidence rates observed in periods after full-activation of OCSPs vs those observed in the preceding quinquennium.

RESULTS

ICC incidence rates diminished with time since OCSPs full-activation: after 6-8years, the IRR was 0.75 (95% CI: 0.67-0.85). The reduction was higher for stages IB-IV (IRR=0.68, 95% CI: 0.58-0.80), squamous cell ICCs (IRR=0.74, 95% CI: 0.64-0.84), and particularly evident among women aged 45-74years. Conversely, incidence rates of micro-invasive (stage IA) ICCs increased, though not significantly, among women aged 25-44years (IRR=1.34, 95% CI: 0.91-1.96). Following full-activation of OCSPs, micro-invasive ICCs were mainly and increasingly diagnosed within OCSPs (up to 72%).

CONCLUSION(S): Within few years from activation, organized screening positively impacted the already low ICC incidence in Italy and favored down-staging.

摘要

目的

通过比较组织性宫颈筛查项目(OCSPs)启动前后的发病率,量化其对浸润性宫颈癌(ICC)发病率的影响。

方法

这项基于人群的调查使用了癌症登记处和OCSPs的个体数据,纳入了1995年至2008年期间诊断为ICC的3557名25至74岁的女性。每个OCSP的全面启动年份定义为至少40%的目标女性被邀请的年份。发病率比(IRRs)及其95%置信区间(95% CIs)通过OCSPs全面启动后各时期观察到的年龄标准化发病率与前一个五年期观察到的发病率之比来计算。

结果

自OCSPs全面启动以来,ICC发病率随时间下降:6至8年后,IRR为0.75(95% CI:0.67 - 0.85)。IB-IV期(IRR = 0.68,95% CI:0.58 - 0.80)、鳞状细胞ICC(IRR = 0.74,95% CI:0.64 - 0.84)的下降幅度更大,在45至74岁女性中尤为明显。相反,在25至44岁女性中,微浸润(IA期)ICC的发病率虽未显著增加,但有所上升(IRR = 1.34,95% CI:0.91 - 1.96)。OCSPs全面启动后,微浸润ICC主要且越来越多地在OCSPs内被诊断出来(高达72%)。

结论

在启动后的几年内,组织性筛查对意大利本就较低的ICC发病率产生了积极影响,并有利于疾病分期的降低。

相似文献

1
Changes in cervical cancer incidence following the introduction of organized screening in Italy.意大利引入有组织的筛查后宫颈癌发病率的变化。
Prev Med. 2015 Jun;75:56-63. doi: 10.1016/j.ypmed.2015.01.034. Epub 2015 Mar 27.
2
Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.意大利浸润性宫颈癌女性的组织化项目内筛查模式与生存情况。
Prev Med. 2013 Sep;57(3):220-6. doi: 10.1016/j.ypmed.2013.05.018. Epub 2013 Jun 1.
3
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.筛查可预防的宫颈癌风险:来自瑞典全国性审计的证据。
J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.
4
Pap test use and cervical cancer incidence in First Nations women living in Manitoba.居住在曼尼托巴省的原住民妇女的巴氏试验使用情况与宫颈癌发病率
Cancer Prev Res (Phila). 2015 Jan;8(1):49-55. doi: 10.1158/1940-6207.CAPR-14-0277. Epub 2014 Nov 17.
5
About invasive cervical cancer: a French population based study between 1998 and 2010.关于浸润性宫颈癌:一项基于1998年至2010年法国人群的研究。
Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:1-6. doi: 10.1016/j.ejogrb.2015.04.007. Epub 2015 May 12.
6
The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.两年与三年一次宫颈筛查间隔推荐对宫颈癌发病率和死亡率的影响:澳大利亚、新西兰和英格兰趋势分析。
Cancer Causes Control. 2013 Sep;24(9):1727-36. doi: 10.1007/s10552-013-0250-9. Epub 2013 Jul 6.
7
Screening history of women with invasive cervical cancer in north-east Italy.意大利东北部浸润性宫颈癌女性的筛查史。
Eur J Obstet Gynecol Reprod Biol. 2010 Oct;152(2):200-4. doi: 10.1016/j.ejogrb.2010.06.005. Epub 2010 Jul 27.
8
Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011.法属圭亚那的宫颈癌筛查:2006年至2011年的筛查率
Bull Soc Pathol Exot. 2015 Dec;108(5):355-9. doi: 10.1007/s13149-015-0460-3. Epub 2015 Nov 25.
9
Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.炎症性肠病与宫颈癌:基于人群的全国性队列研究。
Clin Gastroenterol Hepatol. 2015 Apr;13(4):693-700.e1. doi: 10.1016/j.cgh.2014.07.036. Epub 2014 Jul 30.
10
A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.一项关于鳞状细胞癌和腺癌筛查的瑞典纵向研究:有效性和过度治疗的证据。
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2641-8. doi: 10.1158/1055-9965.EPI-07-0278.

引用本文的文献

1
A Comparison of the National Cervical Cancer Policies in Six Developing Countries with the World Health Organization Recommendations: A Narrative Review.六个发展中国家的国家宫颈癌政策与世界卫生组织建议的比较:叙述性综述
Iran J Public Health. 2023 Jun;52(6):1108-1120. doi: 10.18502/ijph.v52i6.12952.
2
Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review.治疗后宫颈癌患者的性功能和生活质量:系统评价。
Medicina (Kaunas). 2023 Apr 4;59(4):704. doi: 10.3390/medicina59040704.
3
Predictors of CIN2+ in Patients with PAP III-P (ASC-H): A Cross-Sectional Study.
巴氏涂片III级-P(非典型鳞状细胞不排除高度病变,ASC-H)患者中CIN2+的预测因素:一项横断面研究。
Diagnostics (Basel). 2023 Mar 11;13(6):1066. doi: 10.3390/diagnostics13061066.
4
Cervical cancer testing among women aged 30-49 years in the WHO European Region.世界卫生组织欧洲区域 30-49 岁妇女的宫颈癌检测。
Eur J Public Health. 2021 Oct 11;31(4):884-889. doi: 10.1093/eurpub/ckab100.
5
Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program.巴氏涂片筛查对诊断时宫颈癌分期的影响:来自韩国国家癌症筛查计划的结果。
J Gynecol Oncol. 2021 Sep;32(5):e81. doi: 10.3802/jgo.2021.32.e81.
6
A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test.一项针对年轻女性自愿选择接种 HPV 疫苗的回顾性队列研究:首次宫颈癌筛查试验的结果。
Viruses. 2021 Mar 16;13(3):486. doi: 10.3390/v13030486.
7
Leptomeningeal Carcinomatosis of a Poorly Differentiated Cervical Carcinoma Caused by Human Papillomavirus Type 18.人乳头瘤病毒 18 型引起的低分化宫颈癌所致的脑膜癌病。
Viruses. 2021 Feb 16;13(2):307. doi: 10.3390/v13020307.
8
The Cost-Effectiveness Analysis of Cervical Cancer Screening Using a Systematic Invitation System in Lithuania.立陶宛使用系统邀请制进行宫颈癌筛查的成本效益分析。
Int J Environ Res Public Health. 2019 Dec 11;16(24):5035. doi: 10.3390/ijerph16245035.
9
Atti del 52° Congresso Nazionale: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI).第52届全国大会会议记录:意大利卫生、预防医学与公共卫生学会(SItI)
J Prev Med Hyg. 2019 Oct 15;60(3 Suppl 1):E1-E384. doi: 10.15167/2421-4248/jpmh2019.60.3s1. eCollection 2019 Oct.
10
Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania.立陶宛城乡有组织与机会性宫颈癌筛查比较。
Medicina (Kaunas). 2019 Sep 6;55(9):570. doi: 10.3390/medicina55090570.